November 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report January-September 2025. The full report is available on the Company's website. “We are now ...

Space Surveillance Unit's Commercial Data Mission Centre has delivered its first international Joint Commercial Operations-200 (JCO-200) course.Held ...

The Chromebook Plus Spin 514 is like a build-your-own adventure. It packs plenty of power in a premium build, enabling you to ...

The first new Toyota HiLux in a decade brings plenty to the table on the road and in the showroom. Is it enough?

Late-breaking results from clinical trials, debates about lifestyle choices and cardiovascular risk, and improving clinical care with generative AI are among the topics being presented by UC San ...

AnaptysBio plans to advance rosnilimab for RA, with a program update expected in the first half of 2026. Read why ANAB stock ...

The value of GM stock was stable during the week of November 10th, 2025 to November 14th, 2025. See GM stock performance ...

Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...

Revised 2025 Guidance -- Projected cell processing revenue of $93 million to $94 million, representing 26%-28% growth; total ...

Adequate management of COPD is important because hospitalisation for an acute exacerbation of COPD (AECOPD) is associated ...

Q3 2025 Earnings Call Transcript November 13, 2025 Operator: Ladies and gentlemen, thank you for standing by. Welcome to ...

Operator: Good day, ladies and gentlemen. Thank you for standing by, and welcome to the Cerus Corporation Third Quarter 2025 ...